NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 760 filers reported holding NOVARTIS A G in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,524,000 | -67.4% | 21,042 | -61.2% | 1.09% | -64.1% |
| Q4 2015 | $4,671,000 | -10.4% | 54,293 | -4.2% | 3.04% | -5.0% |
| Q3 2015 | $5,212,000 | -6.6% | 56,699 | -0.1% | 3.20% | +9.6% |
| Q2 2015 | $5,579,000 | +5.5% | 56,729 | +5.8% | 2.92% | +2.2% |
| Q1 2015 | $5,290,000 | -36.5% | 53,644 | -48.3% | 2.86% | +4.6% |
| Q4 2014 | $8,336,000 | +23.1% | 103,704 | +44.2% | 2.73% | -23.0% |
| Q3 2014 | $6,771,000 | -15.4% | 71,931 | -18.6% | 3.55% | +12.6% |
| Q2 2014 | $7,999,000 | -4.3% | 88,362 | -10.2% | 3.15% | +4.5% |
| Q1 2014 | $8,362,000 | +0.3% | 98,353 | -5.2% | 3.01% | +10.3% |
| Q4 2013 | $8,336,000 | +4.0% | 103,704 | -0.7% | 2.73% | -3.4% |
| Q3 2013 | $8,014,000 | +9.4% | 104,465 | +0.8% | 2.83% | -0.8% |
| Q2 2013 | $7,326,000 | – | 103,605 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |